Mario E. Lacouture Discusses Adverse Effects of Targeted Therapies

April 19, 2016
Mario E. Lacouture, MD

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.

Therapies that target the immune system can lead to a number of adverse effects, such as fevers and immune-related toxicities affecting various parts of the body. Lacoture emphasizes that timely intervention is crucial for these events so that patients can get the help needed while continuing and getting the full benefit of the treatment.